Lixte Biotechnology (LIXTW) Competitors $0.06 +0.01 (+13.68%) As of 03:59 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsShort InterestTrends LIXTW vs. ATNFW, LBPSW, AARD, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, and BCTXWShould you be buying Lixte Biotechnology stock or one of its competitors? The main competitors of Lixte Biotechnology include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aardvark Therapeutics (AARD), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), and BriaCell Therapeutics (BCTXW). These companies are all part of the "pharmaceutical products" industry. Lixte Biotechnology vs. 180 Life Sciences 4D pharma Aardvark Therapeutics Aesther Healthcare Acquisition Ainos Alvotech Atlantic Coastal Acquisition Corp. II Biofrontera biote BriaCell Therapeutics Lixte Biotechnology (NASDAQ:LIXTW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, dividends, valuation, earnings, profitability, community ranking, risk, institutional ownership and media sentiment. Does the media favor LIXTW or ATNFW? In the previous week, Lixte Biotechnology and Lixte Biotechnology both had 1 articles in the media. Lixte Biotechnology's average media sentiment score of 1.89 beat 180 Life Sciences' score of 1.87 indicating that Lixte Biotechnology is being referred to more favorably in the media. Company Overall Sentiment Lixte Biotechnology Very Positive 180 Life Sciences Very Positive Does the MarketBeat Community favor LIXTW or ATNFW? Lixte Biotechnology and 180 Life Sciences both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformLixte BiotechnologyN/AN/A180 Life SciencesN/AN/A Which has better valuation and earnings, LIXTW or ATNFW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLixte BiotechnologyN/AN/AN/AN/AN/A180 Life SciencesN/AN/AN/AN/AN/A Is LIXTW or ATNFW more profitable? Company Net Margins Return on Equity Return on Assets Lixte BiotechnologyN/A N/A N/A 180 Life Sciences N/A N/A N/A SummaryLixte Biotechnology beats 180 Life Sciences on 1 of the 1 factors compared between the two stocks. Get Lixte Biotechnology News Delivered to You Automatically Sign up to receive the latest news and ratings for LIXTW and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LIXTW vs. The Competition Export to ExcelMetricLixte BiotechnologyBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$115.01M$5.81B$8.43BDividend YieldN/A3.69%4.76%3.97%P/E RatioN/A3.1724.9119.24Price / SalesN/A4,211.67375.92110.19Price / CashN/A13.0138.0534.58Price / BookN/A44.697.324.28Net IncomeN/A-$87.82M$3.18B$247.04M7 Day PerformanceN/A-0.17%-2.94%-3.26%1 Month PerformanceN/A-2.25%-6.83%-6.57%1 Year PerformanceN/A133.43%12.16%4.00% Lixte Biotechnology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LIXTWLixte BiotechnologyN/A$0.05-1.2%N/AN/A$0.00N/A0.004Positive NewsATNFW180 Life SciencesN/A$0.01-3.8%N/A+61.3%$0.00N/A0.007Positive NewsGap DownLBPSW4D pharmaN/AN/AN/AN/A$0.00$522,000.000.00N/AAARDAardvark TherapeuticsN/A$12.73flatN/AN/A$0.00N/A0.0018Positive NewsAEHAWAesther Healthcare AcquisitionN/A$0.03-3.9%N/A-74.7%$0.00N/A0.002Gap UpAIMDWAinosN/A$0.09-57.7%N/A+79.0%$0.00$40,633.000.0040Positive NewsGap UpALVOWAlvotechN/A$2.20-2.7%N/A-50.3%$0.00$391.87M0.004Short Interest ↓Gap UpACABWAtlantic Coastal Acquisition Corp. IIN/A$0.03-2.9%N/A-66.4%$0.00N/A0.004Gap UpBFRIWBiofronteraN/A$0.06-41.9%N/A+132.0%$0.00$35.36M0.0070Gap UpBTMDWbioteN/A$0.08-22.7%N/A-85.9%$0.00$193.06M0.00N/AGap DownBCTXWBriaCell TherapeuticsN/A$0.11-5.0%N/A-94.2%$0.00N/A0.008Short Interest ↓Gap Down Related Companies and Tools Related Companies 180 Life Sciences Competitors 4D pharma Competitors Aardvark Therapeutics Competitors Aesther Healthcare Acquisition Competitors Ainos Competitors Alvotech Competitors Atlantic Coastal Acquisition Corp. II Competitors Biofrontera Competitors biote Competitors BriaCell Therapeutics Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:LIXTW) was last updated on 3/4/2025 by MarketBeat.com Staff From Our Partners77 Hedge Funds Are Betting On This Off-Radar MineralWith surging prices... supply shortages... and growing demand, hedge funds are betting big on potash. In fa...The Tomorrow Investor | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump’s Victory Could Spark Major Gains for Gold – Don’t Miss Out This "Patriot's Tax Shield" lets you defend your wealth with real, solid gold. Our exclusive, free wealth pr...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lixte Biotechnology Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lixte Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LIXTW Stock Alerts